Nucor (NUE) Competitors

In the previous week, ATI had 9 more articles in the media than Nucor. MarketBeat recorded 25 mentions for ATI and 16 mentions for Nucor. Nucor's average media sentiment score of 1.42 beat ATI's score of 1.20 indicating that Nucor is being referred to more favorably in the news media.

ATI has a beta of 1.01, suggesting that its share price is 1% more volatile than the broader market. Comparatively, Nucor has a beta of 1.87, suggesting that its share price is 87% more volatile than the broader market.

76.5% of Nucor shares are owned by institutional investors. 1.0% of ATI shares are owned by insiders. Comparatively, 0.6% of Nucor shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

ATI has a net margin of 10.09% compared to Nucor's net margin of 7.99%. ATI's return on equity of 29.27% beat Nucor's return on equity.

Nucor has higher revenue and earnings than ATI. Nucor is trading at a lower price-to-earnings ratio than ATI, indicating that it is currently the more affordable of the two stocks.

ATI pays an annual dividend of $0.32 per share and has a dividend yield of 0.2%. Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. ATI pays out 9.4% of its earnings in the form of a dividend. Nucor pays out 17.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has raised its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

ATI presently has a consensus price target of $232.00, indicating a potential upside of 10.20%. Nucor has a consensus price target of $272.38, indicating a potential upside of 4.37%. Given ATI's stronger consensus rating and higher probable upside, equities analysts plainly believe ATI is more favorable than Nucor.

Nucor has a beta of 1.87, suggesting that its share price is 87% more volatile than the broader market. Comparatively, Cabot has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market.

In the previous week, Nucor had 3 more articles in the media than Cabot. MarketBeat recorded 16 mentions for Nucor and 13 mentions for Cabot. Nucor's average media sentiment score of 1.42 beat Cabot's score of 1.02 indicating that Nucor is being referred to more favorably in the media.

76.5% of Nucor shares are held by institutional investors. Comparatively, 93.2% of Cabot shares are held by institutional investors. 0.6% of Nucor shares are held by company insiders. Comparatively, 3.1% of Cabot shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.3%. Nucor pays out 17.9% of its earnings in the form of a dividend. Cabot pays out 53.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years and Cabot has increased its dividend for 14 consecutive years.

Nucor has a net margin of 7.99% compared to Cabot's net margin of 5.23%. Cabot's return on equity of 20.29% beat Nucor's return on equity.

Nucor currently has a consensus target price of $272.38, indicating a potential upside of 4.37%. Cabot has a consensus target price of $89.00, indicating a potential upside of 9.24%. Given Cabot's higher probable upside, analysts plainly believe Cabot is more favorable than Nucor.

Nucor has higher revenue and earnings than Cabot. Nucor is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

In the previous week, Nucor had 6 more articles in the media than Chemours. MarketBeat recorded 16 mentions for Nucor and 10 mentions for Chemours. Nucor's average media sentiment score of 1.42 beat Chemours' score of 1.28 indicating that Nucor is being referred to more favorably in the media.

Nucor has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

76.5% of Nucor shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 0.6% of Nucor shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Nucor presently has a consensus price target of $272.38, indicating a potential upside of 4.37%. Chemours has a consensus price target of $20.10, indicating a potential upside of 31.54%. Given Chemours' higher possible upside, analysts clearly believe Chemours is more favorable than Nucor.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.3%. Nucor pays out 17.9% of its earnings in the form of a dividend. Chemours pays out -18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

Nucor has a net margin of 7.99% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Nucor's return on equity.

Nucor has a beta of 1.87, suggesting that its share price is 87% more volatile than the broader market. Comparatively, Chemours has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market.

Nucor currently has a consensus target price of $272.38, indicating a potential upside of 4.37%. Celanese has a consensus target price of $63.71, indicating a potential upside of 42.19%. Given Celanese's higher probable upside, analysts clearly believe Celanese is more favorable than Nucor.

Nucor has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market. Comparatively, Celanese has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

In the previous week, Celanese had 2 more articles in the media than Nucor. MarketBeat recorded 18 mentions for Celanese and 16 mentions for Nucor. Nucor's average media sentiment score of 1.42 beat Celanese's score of 1.25 indicating that Nucor is being referred to more favorably in the media.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.3%. Nucor pays out 17.9% of its earnings in the form of a dividend. Celanese pays out -1.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

76.5% of Nucor shares are held by institutional investors. Comparatively, 98.9% of Celanese shares are held by institutional investors. 0.6% of Nucor shares are held by insiders. Comparatively, 0.3% of Celanese shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Nucor has a net margin of 7.99% compared to Celanese's net margin of -12.04%. Celanese's return on equity of 13.04% beat Nucor's return on equity.

Nucor has higher revenue and earnings than Celanese. Celanese is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.